NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ||
Founding Date | Founding Date 2011 | Founding Date 1992 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Gaithersburg, US HQ | Locations Somerville, US HQ |
Employees | Employees 5032% decrease | Employees 32338% decrease |
Valuation ($) | Valuation ($) 372.4 k | Valuation ($) 95.4 m |
Financial | ||
Net income | Net income ($32.3m) (FY, 2023) | Net income ($240.7m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 33.8m | Total funding raised $ 409m |

Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View company